Endava (NYSE: DAVA) received a downgrade from Wall Street Zen, which lowered its rating from “hold” to “sell” in a recent report. Additionally, Morgan Stanley reduced its price target for Endava shares from $11.00 to $8.00, maintaining an “equal weight” rating.
Other analysts have also provided updated evaluations on Endava, reflecting increased caution about the company’s near-term outlook.
**Why this matters**
The downgrades and lower price targets suggest growing concerns among analysts regarding Endava’s performance and future prospects. Investors may want to consider these revised assessments when making decisions about holding or selling the stock.
Source: NewsData